1. Home
  2. GH vs TKO Comparison

GH vs TKO Comparison

Compare GH & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$85.25

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$196.08

Market Cap

14.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
TKO
Founded
2011
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
14.5B
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
GH
TKO
Price
$85.25
$196.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
17
Target Price
$120.05
$225.20
AVG Volume (30 Days)
1.9M
1.3M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
1.60%
EPS Growth
6.74
11200.00
EPS
N/A
2.26
Revenue
$982,021,000.00
$4,735,151,000.00
Revenue This Year
$33.30
$23.69
Revenue Next Year
$28.19
$0.63
P/E Ratio
N/A
$86.77
Revenue Growth
32.88
68.85
52 Week Low
$36.36
$141.44
52 Week High
$120.74
$226.94

Technical Indicators

Market Signals
Indicator
GH
TKO
Relative Strength Index (RSI) 46.25 45.83
Support Level $82.33 $194.71
Resistance Level $90.28 $212.89
Average True Range (ATR) 5.51 6.64
MACD -0.10 0.39
Stochastic Oscillator 47.85 47.46

Price Performance

Historical Comparison
GH
TKO

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four principal activities: Media Rights and Content, Live Events, Sponsorship, and Consumer Products Licensing. The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events, sponsorship, and consumer products licensing agreements of UFC-branded products.

Share on Social Networks: